Skip to main content
. 2015 Nov;29(11):1152–1158. doi: 10.1177/0269881115602487

Figure 1.

Figure 1.

Mortality risks (nalmefene versus placebo) assuming an OR = 0.41 for reduced drinking (including abstinence).

Note: I2 = 6%, p = 0.37 for overall analysis, random-effects model.